291 related articles for article (PubMed ID: 32965787)
1. Airway mechanics after withdrawal of a leukotriene receptor antagonist in children with mild persistent asthma: Double-blind, randomized, cross-over study.
Kim JH; Lee S; Shin YH; Ha EK; Lee SW; Kim MA; Yoon JW; Baek HS; Choi SH; Han MY
Pediatr Pulmonol; 2020 Dec; 55(12):3279-3286. PubMed ID: 32965787
[TBL] [Abstract][Full Text] [Related]
2. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
Rabinovitch N; Mauger DT; Reisdorph N; Covar R; Malka J; Lemanske RF; Morgan WJ; Guilbert TW; Zeiger RS; Bacharier LB; Szefler SJ
J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
[TBL] [Abstract][Full Text] [Related]
3. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma.
Montuschi P; Mondino C; Koch P; Ciabattoni G; Barnes PJ; Baviera G
Chest; 2007 Dec; 132(6):1876-81. PubMed ID: 18079221
[TBL] [Abstract][Full Text] [Related]
4. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.
Gelb AF; Taylor CF; Shinar CM; Gutierrez CA; Zamel N
Can Respir J; 2008; 15(4):193-8. PubMed ID: 18551200
[TBL] [Abstract][Full Text] [Related]
5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
6. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.
Bisgaard H; Loland L; Oj JA
Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811
[TBL] [Abstract][Full Text] [Related]
7. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
9. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
[TBL] [Abstract][Full Text] [Related]
10. Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.
Kanniess F; Richter K; Janicki S; Schleiss MB; Jörres RA; Magnussen H
Eur Respir J; 2002 Nov; 20(5):1080-7. PubMed ID: 12449158
[TBL] [Abstract][Full Text] [Related]
11. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
Yurdakul AS; Taci N; Eren A; Sipit T
Respir Med; 2003 Dec; 97(12):1313-9. PubMed ID: 14682413
[TBL] [Abstract][Full Text] [Related]
13. Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study.
Bratton DL; Lanz MJ; Miyazawa N; White CW; Silkoff PE
Pediatr Pulmonol; 1999 Dec; 28(6):402-7. PubMed ID: 10587413
[TBL] [Abstract][Full Text] [Related]
14. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
15. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
16. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Bateman ED; Goehring UM; Richard F; Watz H
J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
[TBL] [Abstract][Full Text] [Related]
17. The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?
Sahiner UM; Arik Yilmaz E; Fontanella S; Haider S; Soyer O; Custovic A; Kalayci O; Sackesen C
Int Arch Allergy Immunol; 2021; 182(12):1212-1221. PubMed ID: 34518469
[TBL] [Abstract][Full Text] [Related]
18. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
Garcia Garcia ML; Wahn U; Gilles L; Swern A; Tozzi CA; Polos P
Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Buchvald F; Bisgaard H
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
[TBL] [Abstract][Full Text] [Related]
20. Childhood asthma clusters and response to therapy in clinical trials.
Chang TS; Lemanske RF; Mauger DT; Fitzpatrick AM; Sorkness CA; Szefler SJ; Gangnon RE; Page CD; Jackson DJ;
J Allergy Clin Immunol; 2014 Feb; 133(2):363-9. PubMed ID: 24139497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
